Merck KGaA (MKGAF) Stock Chart & Stock Price History → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free MKGAF Stock Alerts $184.13 +0.72 (+0.39%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Merck KGaA Stock Price Performance5 Day Performance+0.89%1 Month Performance+13.66%3 Month Performance+6.43%6 Month Performance+4.03%Year-To-Date Performance+14.37%1 Year PerformanceN/A Receive MKGAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. MKGAF Stock Chart for Sunday, June, 2, 2024 MKGAF Chart by TradingView Merck KGaA Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$183.42$184.13+0.39%$184.13$184.131 shs$23.80 billion05/30/2024$178.59$183.42+2.70%$183.42$176.264 shs$23.70 billion05/29/2024$182.50$178.59-2.14%$178.59$178.591 shs$23.08 billion05/28/2024$177.62$182.50+2.75%$185.91$178.39160 shs$23.59 billion05/27/2024$177.62$177.62$184.94$177.62100 shs$22.96 billion05/24/2024$188.06$177.62-5.55%$184.94$177.6233 shs$22.96 billion Get the Latest News and Ratings for MKGAF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$182.28$188.06+3.17%$188.06$180.40222 shs$24.30 billion05/22/2024$178.25$182.28+2.26%$182.28$181.0823 shs$23.56 billion05/21/2024$183.00$178.25-2.60%$178.25$176.0812 shs$23.04 billion05/20/2024$180.00$183.00+1.67%$184.39$180.0082 shs$23.65 billion05/17/2024$182.50$180.00-1.37%$185.50$178.58261 shs$23.26 billion05/16/2024$175.59$182.50+3.93%$182.57$181.46757 shs$23.59 billion05/15/2024$172.81$175.59+1.61%$178.46$175.59290 shs$22.69 billion05/14/2024$164.31$172.81+5.18%$172.81$168.75176 shs$22.33 billion05/13/2024$168.35$164.31-2.40%$168.46$164.3142 shs$21.23 billion05/10/2024$165.43$168.35+1.76%$168.35$166.252,003 shs$21.76 billion05/09/2024$165.15$165.43+0.17%$165.43$165.431 shs$21.38 billion05/08/2024$168.78$165.15-2.15%$166.54$165.15183 shs$21.34 billion05/07/2024$162.75$168.78+3.71%$168.78$168.781 shs$21.81 billion05/06/2024$162.23$162.75+0.32%$166.56$160.73666 shs$21.03 billion05/03/2024$162.00$162.23+0.14%$165.97$161.8258 shs$20.97 billion05/02/2024$154.11$162.00+5.12%$163.20$158.41223 shs$20.94 billion05/01/2024$161.00$154.11-4.28%$162.15$154.1121 shs$19.92 billion04/30/2024$163.26$161.00-1.39%$162.29$161.0056 shs$20.81 billion04/29/2024$157.08$163.26+3.94%$163.26$160.0442 shs$21.10 billion04/26/2024$165.33$157.08-4.99%$166.52$157.0882 shs$20.30 billion04/25/2024$158.36$165.33+4.40%$165.33$154.801,092 shs$21.37 billion04/24/2024$160.51$158.36-1.33%$168.14$158.36111 shs$20.47 billion04/23/2024$156.00$160.51+2.89%$160.51$160.5118 shs$20.74 billion04/22/2024$156.00$156.00$156.00$152.0563 shs$20.16 billion04/19/2024$158.75$156.00-1.73%$156.04$154.32361 shs$20.16 billion04/18/2024$158.75$158.75$160.52$156.85313 shs$20.52 billion04/17/2024$162.38$158.75-2.24%$160.52$156.85313 shs$20.52 billion04/16/2024$162.00$162.38+0.24%$162.38$162.385 shs$20.99 billion04/15/2024$163.51$162.00-0.92%$163.69$158.98267 shs$20.94 billion04/12/2024$164.90$163.51-0.84%$163.75$161.78285 shs$21.13 billion04/11/2024$161.50$164.90+2.11%$164.90$161.9538 shs$21.31 billion04/10/2024$168.25$161.50-4.01%$162.63$160.80556 shs$20.87 billion04/09/2024$162.62$168.25+3.46%$168.25$165.10113 shs$21.74 billion04/08/2024$162.00$162.62+0.38%$166.63$162.6229 shs$21.02 billionDo This Before July 30 2024 To Claim Trump’s Gift (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024.04/05/2024$169.10$162.00-4.20%$167.90$160.57205 shs$20.94 billion04/04/2024$171.50$169.10-1.40%$170.60$169.10566 shs$21.85 billion04/03/2024$169.25$171.50+1.33%$173.19$169.4120,068 shs$22.16 billion04/02/2024$176.50$169.25-4.11%$169.25$169.2522 shs$21.87 billion04/01/2024$176.81$176.50-0.18%$180.43$172.94664 shs$22.81 billion03/29/2024$176.81$176.81$178.15$175.73617 shs$22.85 billion03/28/2024$174.23$176.81+1.48%$178.15$175.73617 shs$22.85 billion03/27/2024$172.45$174.23+1.03%$174.23$172.14437 shs$22.52 billion03/26/2024$173.13$172.45-0.39%$173.50$171.38448 shs$22.29 billion03/25/2024$171.24$173.13+1.10%$174.79$172.54208 shs$22.38 billion03/22/2024$175.50$171.24-2.43%$180.68$171.2497 shs$22.13 billion03/21/2024$168.18$175.50+4.35%$175.50$174.22199 shs$22.68 billion03/20/2024$171.00$168.18-1.65%$168.18$168.1831 shs$21.74 billion03/19/2024$170.50$171.00+0.29%$171.55$170.78390 shs$22.10 billion03/18/2024$174.86$170.50-2.49%$171.03$170.46346 shs$22.04 billion03/15/2024$173.50$174.86+0.78%$175.54$173.48176 shs$22.60 billion03/14/2024$175.72$173.50-1.26%$174.69$173.50474 shs$22.42 billion03/13/2024$176.00$175.72-0.16%$175.72$175.725,206 shs$22.71 billion03/12/2024$171.75$176.00+2.47%$176.00$174.94104 shs$22.75 billion03/11/2024$172.00$171.75-0.15%$171.75$169.03255 shs$22.20 billion03/08/2024$174.75$172.00-1.57%$173.00$172.00285 shs$22.23 billion03/07/2024$174.75$174.75$174.75$171.78128 shs$22.58 billion03/06/2024$173.20$174.75+0.89%$174.75$174.3842 shs$22.59 billion03/05/2024$173.50$173.20-0.17%$173.70$170.75165 shs$22.38 billion03/04/2024$173.00$173.50+0.29%$173.50$170.00176 shs$22.42 billion03/01/2024$170.00$173.00+1.76%$173.00$171.26350 shs$22.36 billion Related Companies: Genmab A/S Stock Price Chart Alnylam Pharmaceuticals Stock Price Chart Teva Pharmaceutical Industries Stock Price Chart Astellas Pharma Stock Price Chart BeiGene Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Viatris Stock Price Chart United Therapeutics Stock Price Chart Sarepta Therapeutics Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart Receive MKGAF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:MKGAF) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.